As the peptide industry continues to grow, Certificates of Analysis (COAs) have become one of the most important tools for evaluating research compound quality and analytical transparency. Despite being widely referenced across peptide suppliers, many researchers and buyers still do not fully understand what a COA actually shows — or what warning signs to look for.
A properly structured COA can provide valuable insight into peptide identity, purity, batch consistency and testing methodology. However, not all COAs are created equally, and analytical transparency can vary significantly between suppliers.
This article explains how to read a peptide COA, what the key sections mean, how HPLC testing works and why independent verification remains essential when evaluating research compounds.
What Is A COA?
A COA, or Certificate of Analysis, is a document that summarises analytical testing performed on a specific peptide batch.
The purpose of a COA is to provide verification regarding:
- Compound identity
- Purity percentage
- Batch traceability
- Testing methods
- Analytical consistency
For research environments, a COA acts as an important quality assurance document supporting transparency and verification standards.
Why COAs Matter
As peptide demand has increased globally, analytical transparency has become increasingly important.
A legitimate COA helps researchers:
- Verify purity claims
- Confirm batch information
- Review analytical methods
- Assess supplier transparency
- Identify potential inconsistencies
Without proper testing documentation, it becomes difficult to evaluate the reliability or quality of a research compound.
The Most Important Sections Of A COA
Although formats vary between laboratories, most peptide COAs contain several core sections.
1. Compound Name
The COA should clearly identify the peptide being tested.
Examples may include:
- BPC-157
- TB-500
- Retatrutide
- Semaglutide
Researchers should ensure:
- Naming is consistent
- Spelling is accurate
- Compound information matches supplier documentation
Incorrect or vague naming can sometimes indicate poor documentation standards.
2. Batch Number
A legitimate COA should always contain a unique batch or lot number.
Batch numbers are important because they help support:
- Traceability
- Manufacturing consistency
- Quality control tracking
- Verification between orders
If a supplier provides identical COAs without changing batch numbers, this may be a warning sign.
3. Purity Percentage
One of the most closely examined sections of a peptide COA is the purity result.
Purity percentages commonly include:
- 95%
- 98%
- 99%
Higher purity generally indicates:
- Fewer impurities
- Improved manufacturing precision
- Better analytical consistency
However, purity claims should always be supported by legitimate testing data rather than simple written percentages alone.
4. HPLC Testing Information
Many peptide COAs include High-Performance Liquid Chromatography (HPLC) results.
HPLC testing is used to:
- Analyse peptide composition
- Measure purity
- Detect impurities
- Assess batch consistency
Researchers should review:
- Chromatogram quality
- Peak clarity
- Retention times
- Presence of secondary peaks
Well-structured HPLC analysis is one of the strongest indicators of professional analytical verification.
5. Chromatogram Analysis
The chromatogram is the visual graph generated during HPLC testing.
When reviewing chromatograms, researchers often look for:
- A dominant primary peak
- Minimal secondary peaks
- Clear analytical presentation
- Consistent retention times
Multiple unexpected peaks may indicate:
- Impurities
- Degradation
- Manufacturing inconsistencies
Chromatograms remain one of the most important sections of peptide analytical documentation.
6. Mass Spectrometry Results
Some COAs also include mass spectrometry analysis.
Mass spectrometry helps verify:
- Molecular weight
- Compound identity
- Structural consistency
When combined with HPLC testing, mass spectrometry provides stronger analytical confirmation of peptide authenticity.
7. Testing Date
A legitimate COA should contain:
- Testing dates
- Analysis dates
- Laboratory timestamps
Missing or outdated dates may reduce confidence in analytical transparency and batch relevance.
8. Laboratory Information
Researchers should always examine whether:
- The testing laboratory is identified
- Analytical methods are specified
- Documentation appears professional and traceable
Third-party laboratory verification is generally viewed as stronger than supplier-only documentation.
Common COA Red Flags
When evaluating peptide suppliers, common warning signs may include:
- Missing batch numbers
- Generic templates reused across compounds
- No chromatogram data
- No laboratory details
- Unrealistic purity claims
- Poor formatting or inconsistent information
As the peptide industry becomes increasingly competitive, analytical transparency remains one of the strongest indicators of supplier reliability.
Why Third-Party Testing Matters
Independent testing helps support:
- Compound verification
- Purity accuracy
- Batch consistency
- Research confidence
- Quality control transparency
At Nova Research Supply, emphasis is placed on clinically presented research compounds, transparent analytical documentation and verification-focused sourcing standards.
Frequently Asked Questions
What does COA stand for?
COA stands for Certificate of Analysis.
What is HPLC testing?
HPLC (High-Performance Liquid Chromatography) is an analytical method used to assess peptide purity and composition.
Why are chromatograms important?
Chromatograms visually display compound separation and help identify purity levels and potential impurities.
What should a legitimate COA include?
A professional COA commonly includes:
- Compound name
- Batch number
- Purity results
- HPLC data
- Testing dates
- Laboratory information
Why is third-party testing important?
Independent analysis helps confirm compound identity, purity and manufacturing consistency.
Final Thoughts
Certificates of Analysis play a critical role in peptide verification and analytical transparency. In a rapidly expanding industry where sourcing standards can vary significantly, understanding how to properly evaluate a COA has become increasingly important for researchers and laboratories alike.
By reviewing purity data, chromatograms, batch numbers and testing methodologies carefully, researchers can make more informed decisions regarding peptide sourcing and analytical reliability.
For those seeking clinically presented, verification-focused research compounds, maintaining emphasis on transparency, independent testing and batch integrity remains essential in today’s evolving peptide landscape.
